Journal
CANCER DETECTION AND PREVENTION
Volume 28, Issue 2, Pages 88-93Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.cdp.2003.12.009
Keywords
prostate; high-grade prostatic intraepithelial neoplasia; HIF-1; immunohistochemistry
Categories
Funding
- NATIONAL CANCER INSTITUTE [P50CA058236] Funding Source: NIH RePORTER
- NCI NIH HHS [CA-58236] Funding Source: Medline
Ask authors/readers for more resources
dHypoxia-inducible factor 1 (HIF-1) activates the transcription of genes encoding glucose transporters, glycolytic enzymes, and vascular endothelial growth factor (VEGF). HIF-1alpha is a major subunit of HIF-1 heterodimer. In this study, an immunohistochemical analysis of HIF-1alpha was focused on clinical specimens containing high-grade prostate intraepithelial neoplasia lesions since high-grade prostate intraepithelial neoplasia is considered the precursor of a majority of invasive prostate adenocarcinoma and presents the increased activity of angiogenesis. HIF-1alpha was up-regulated in 11 of 14 high-grade prostate intraepithelial neoplasia lesions identified in a total 10 prostate biopsies relative to the respective normal epithelium, stromal cells, and benign prostatic hyperplasia (BPH). Moreover, up-regulation of HIF-1alpha in adjacent prosate cancer lesions was more enhanced in high-grade intraepithelial neoplasia. The results suggest that up-regulation of HIF-1alpha is an earlyevent in prostatecarcinogenesis, and that HIF-1alpha may become a potential target for prostate cancer prevention and a surrogate biomarker for monitoring pre-malignant lesions of the prostate. (C) 2004 Published by Elsevier Ltd. on behalf of Inernational Society for Preventive Oncology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available